KORU Medical Systems, Inc. (KRMD) Financial Ratios
27 years of historical data (1999–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
N/A
—
5yr avg: N/A
30Y Low4.4·High61.4
P/FCF
N/A
—
5yr avg: N/A
30Y Low8.0·High182.9
P/B Ratio
↑
10.57
↑+30% vs avg
5yr avg: 8.10
30Y Low1.5·High22.7
ROE
↓
-15.6%
↓+44% vs avg
5yr avg: -27.9%
30Y Low-135%·High102%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low0.3·High24.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
KRMD Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
KORU Medical Systems, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $179M | $268M | $176M | $112M | $161M | $133M | $252M | $255M | $64M | $48M | $16M |
| Enterprise Value | $174M | $263M | $171M | $105M | $148M | $108M | $225M | $250M | $60M | $44M | $13M |
| P/E Ratio → | -68.30 | — | — | — | — | — | — | 453.47 | 70.51 | 44.17 | — |
| P/S Ratio | 4.36 | 6.52 | 5.24 | 3.93 | 5.76 | 5.67 | 10.44 | 11.01 | 3.70 | 3.00 | 1.31 |
| P/B Ratio | 10.57 | 15.74 | 10.49 | 5.51 | 5.13 | 3.65 | 6.98 | 22.70 | 7.17 | 6.26 | 2.41 |
| P/FCF | — | — | — | — | — | — | — | — | 64.32 | 70.41 | — |
| P/OCF | 387.41 | 580.33 | — | — | — | — | — | 795.55 | 43.40 | 53.33 | — |
P/E links to full P/E history page with 30-year chart
KRMD EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 6.39 | 5.07 | 3.69 | 5.31 | 4.62 | 9.32 | 10.78 | 3.49 | 2.76 | 1.04 |
| EV / EBITDA | — | — | — | — | — | — | — | 269.55 | 41.04 | 24.56 | — |
| EV / EBIT | — | — | — | — | — | — | 188.98 | 62.37 | 29.31 | 29.66 | — |
| EV / FCF | — | — | — | — | — | — | — | — | 60.57 | 64.58 | — |
KRMD Profitability
Margins and return-on-capital ratios measuring operating efficiency
KORU Medical Systems, Inc. earns an operating margin of -7.2%. Operating margins have expanded from -36.0% to -7.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -15.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.3% | 60.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | 59.2% | 61.6% |
| Operating Margin | -7.2% | -7.2% | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% | 2.5% | 6.7% | 9.3% | -6.0% |
| Net Profit Margin | -6.4% | -6.4% | -18.0% | -48.2% | -31.0% | -19.4% | -5.0% | 2.4% | 5.2% | 6.8% | -4.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -15.6% | -15.6% | -32.6% | -53.2% | -25.5% | -12.6% | -5.1% | 5.6% | 11.0% | 15.1% | -8.0% |
| ROA | -9.5% | -9.5% | -21.8% | -38.8% | -20.7% | -11.2% | -4.5% | 4.6% | 9.2% | 12.4% | -6.5% |
| ROIC | -19.5% | -19.5% | -39.4% | -47.9% | -52.8% | -50.6% | -12.7% | 8.0% | 19.6% | 31.5% | -16.3% |
| ROCE | -14.9% | -14.9% | -29.3% | -34.6% | -30.0% | -19.3% | -5.3% | 5.7% | 14.0% | 20.5% | -10.6% |
KRMD Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $9M exceeds total debt of $3M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.21 | 0.21 | 0.24 | 0.22 | 0.16 | 0.02 | 0.01 | 0.03 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | 0.41 | — | — | — |
| Net Debt / Equity | — | -0.32 | -0.33 | -0.35 | -0.40 | -0.68 | -0.75 | -0.49 | -0.42 | -0.52 | -0.50 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | -5.93 | -2.54 | -2.22 | — |
| Debt / FCF | — | — | — | — | — | — | — | — | -3.74 | -5.83 | — |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | -410.82 |
Net cash position: cash ($9M) exceeds total debt ($3M)
KRMD Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
KORU Medical Systems, Inc.'s current ratio of 2.44x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.99x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 4.55x to 2.44x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.44 | 2.44 | 2.66 | 4.55 | 4.28 | 7.79 | 10.24 | 4.94 | 5.70 | 5.00 | 4.88 |
| Quick Ratio | 1.99 | 1.99 | 2.27 | 3.77 | 3.36 | 6.51 | 8.37 | 3.95 | 4.37 | 3.95 | 3.91 |
| Cash Ratio | 1.08 | 1.08 | 1.33 | 2.58 | 2.50 | 5.29 | 7.45 | 2.44 | 2.36 | 2.67 | 2.57 |
| Asset Turnover | — | 1.46 | 1.24 | 1.00 | 0.66 | 0.57 | 0.61 | 1.67 | 1.65 | 1.72 | 1.50 |
| Inventory Turnover | 4.44 | 4.44 | 4.39 | 3.39 | 1.96 | 1.59 | 1.35 | 3.48 | 3.11 | 3.93 | 3.49 |
| Days Sales Outstanding | — | 57.95 | 65.07 | 51.77 | 46.57 | 55.83 | 38.84 | 50.97 | 29.99 | 42.54 | 49.72 |
KRMD Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
KORU Medical Systems, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | 0.2% | 1.4% | 2.3% | — |
| FCF Yield | — | — | — | — | — | — | — | — | 1.6% | 1.4% | — |
| Buyback Yield | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 1.4% | 0.0% | 0.1% | 0.0% | 0.9% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 1.4% | 0.0% | 0.1% | 0.0% | 0.9% |
| Shares Outstanding | — | $46M | $46M | $46M | $45M | $44M | $42M | $39M | $39M | $38M | $38M |
Peer Comparison
Compare KRMD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 KRMDYou | $179M | -68.3 | — | — | 60.3% | -7.2% | -15.6% | -19.5% | — |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 INFU | $190M | 30.4 | 7.5 | 8.0 | 56.0% | 8.3% | 11.5% | 12.5% | 0.1 |
 LMAT | $2B | 37.3 | 29.3 | 28.7 | 71.5% | 27.2% | 15.8% | 9.7% | 2.4 |
 BDX | $52B | 24.7 | 14.0 | 19.5 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 BAX | $10B | -11.4 | 27.2 | 31.8 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 ICU | $122M | -0.5 | — | — | 95.7% | -986.6% | -295.2% | — | — |
 AVNS | $1B | -17.1 | — | 27.1 | 49.8% | -8.8% | -8.5% | -5.4% | — |
 MMSI | $4B | 31.6 | 14.0 | 18.6 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 NXRT | $684M | -21.4 | 18.0 | 8.2 | 84.3% | 11.1% | -8.9% | 1.1% | 12.6 |
 TNDM | $1B | -5.0 | — | — | 52.3% | -7.7% | -97.9% | -10.0% | — |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 27 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
KRMD — Frequently Asked Questions
Quick answers to the most common questions about buying KRMD stock.
What is KORU Medical Systems, Inc.'s P/E ratio?
KORU Medical Systems, Inc.'s current P/E ratio is -68.3x. The historical average is 23.1x.
What is KORU Medical Systems, Inc.'s ROE?
KORU Medical Systems, Inc.'s return on equity (ROE) is -15.6%. The historical average is -3.5%.
Is KRMD stock overvalued?
Based on historical data, KORU Medical Systems, Inc. is trading at a P/E of -68.3x. Compare with industry peers and growth rates for a complete picture.
What are KORU Medical Systems, Inc.'s profit margins?
KORU Medical Systems, Inc. has 60.3% gross margin and -7.2% operating margin.